Editorial: Novel insights into CAR T-cell associated neurotoxicity

Editorial: Novel insights into CAR T-cell associated neurotoxicity

Bibliographic Details
Main Author:	Stella Bouziana
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Neurology
Subjects:	CAR T-cells ICANS neurotoxicity hematological malignancies solid tumors
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1322843/full

Similar Items

Novel pathophysiological insights into CAR-T cell associated neurotoxicity
by: Vassilis Genoud, et al.
Published: (2023-03-01)

Transverse myelitis after anti‐CD19 directed CAR T cell therapy for relapsed large B cell lymphoma
by: Semira Sheikh, et al.
Published: (2022-02-01)

Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome
by: Tim Lakomy, et al.
Published: (2023-02-01)

CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap
by: Lidia Gatto, et al.
Published: (2023-06-01)

CAR T-cell-associated neurotoxicity in central nervous system hematologic disease: Is it still a concern?
by: Roser Velasco, et al.
Published: (2023-04-01)

A systematic framework for predictive biomarkers in immune effector cell-associated neurotoxicity syndrome
by: Omar H. Butt, et al.
Published: (2023-02-01)

Emerging Novel Combined CAR-T Cell Therapies
by: Anh Nguyen, et al.
Published: (2022-03-01)

Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies
by: Ali Keshavarz, et al.
Published: (2022-09-01)

CAR T Cell Therapy in Hematological Malignancies: Implications of the Tumor Microenvironment and Biomarkers on Efficacy and Toxicity
by: Jing Yuan Tan, et al.
Published: (2022-06-01)

CAR-T cell combination therapy: the next revolution in cancer treatment
by: Maysoon Al-Haideri, et al.
Published: (2022-11-01)

CAR T-Cell Therapy in Hematological Malignancies
by: Theresa Haslauer, et al.
Published: (2021-08-01)

Secretory co-factors in next-generation cellular therapies for cancer
by: Atsushi Okuma, et al.
Published: (2022-08-01)

Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell Therapies
by: Christopher Schorr, et al.
Published: (2023-05-01)

Chimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle Cancer
by: Amy J. Petty, et al.
Published: (2020-03-01)

Challenges and strategies associated with CAR-T cell therapy in blood malignancies
by: Zhaoyun Liu, et al.
Published: (2024-02-01)

CAR-T cell therapy for hematological malignancies: Limitations and optimization strategies
by: Jiawen Huang, et al.
Published: (2022-09-01)

Editorial: The mechanism and novel strategies of overcoming resistance of hematological malignancies to CAR-T cell killing
by: Tingting Zhang, et al.
Published: (2022-12-01)

Building safety into CAR-T therapy
by: Daniel T. Peters, et al.
Published: (2023-12-01)

Resistance Mechanisms to CAR T-Cell Therapy and Overcoming Strategy in B-Cell Hematologic Malignancies
by: Moo-Kon Song, et al.
Published: (2019-10-01)

Post-mortem neuropathologic examination of a 6-case series of CAR T-cell treated patients
by: Núria Vidal Robau, et al.
Published: (2022-01-01)

Interleukin Inhibitors in Cytokine Release Syndrome and Neurotoxicity Secondary to CAR-T Therapy
by: Puri Ferreros, et al.
Published: (2022-07-01)

Current status and future perspective of natural killer cell therapy for cancer
by: Zhao Xiangyu, et al.
Published: (2023-08-01)

How can Cytokine-induced killer cells overcome CAR-T cell limits
by: Elisa Cappuzzello, et al.
Published: (2023-08-01)

CAR T cells: engineered immune cells to treat brain cancers and beyond
by: Zoufang Huang, et al.
Published: (2023-01-01)

The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions
by: Yanping Li, et al.
Published: (2022-10-01)

Harnessing Biomaterials for Safeguarding Chimeric Antigen Receptor T Cell Therapy: An Artful Expedition in Mitigating Adverse Effects
by: Zhaozhao Chen, et al.
Published: (2024-01-01)

Systematic Review of Available CAR-T Cell Trials around the World
by: Luciana Rodrigues Carvalho Barros, et al.
Published: (2022-05-01)

It Is in the Eye of the Beholder: Ocular Ultrasound Enhanced Monitoring of Neurotoxicity after CAR-T Cell Therapy
by: Juan Esteban Garcia-Robledo, et al.
Published: (2022-12-01)

Modeling Patient-Specific CAR-T Cell Dynamics: Multiphasic Kinetics via Phenotypic Differentiation
by: Emanuelle A. Paixão, et al.
Published: (2022-11-01)

Editorial: Immunotherapy for hematological malignancies in children
by: Yusi Zhou, et al.
Published: (2023-10-01)

Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments
by: Gunjan Dagar, et al.
Published: (2023-07-01)

Strategies for Reducing Toxicity and Enhancing Efficacy of Chimeric Antigen Receptor T Cell Therapy in Hematological Malignancies
by: Haobing Wang, et al.
Published: (2023-05-01)

Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
by: Tyler Fugere, et al.
Published: (2023-10-01)

CAR T-Cell Therapy in Children with Solid Tumors
by: Marika Kulczycka, et al.
Published: (2023-03-01)

The journey of CAR-T therapy in hematological malignancies
by: Junru Lu, et al.
Published: (2022-10-01)

Engineering Metabolism of Chimeric Antigen Receptor (CAR) Cells for Developing Efficient Immunotherapies
by: Joslyn L. Mangal, et al.
Published: (2021-03-01)

The new era of immunological treatment, last updated and future consideration of CAR T cell-based drugs
by: Kaveh Hadiloo, et al.
Published: (2024-05-01)

Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield
by: Yuna Jo, et al.
Published: (2020-07-01)

The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
by: Lara Herrera, et al.
Published: (2021-10-01)

Chimeric antigen receptor T (CAR‐T) cells: Novel cell therapy for hematological malignancies
by: Samane Abbasi, et al.
Published: (2023-04-01)